Mosaic
Fuel breakthroughs in oncology with spatial omics
Learn how we are building the MOSAIC dataset
Apply AI to large-scale spatial omics to discover:
Targets
New therapeutic targets
Subgroups
New patient subgroups
Biomarkers
New diagnostic and prognostic spatial biomarkers
Treatment
New treatment response and resistance mechanisms
Why work with Owkin
Work with Owkin to leverage spatial omics data
Pioneering large-scale spatial biology with world-leading academic and industry partners
7,000
Patients
100 times larger than existing spatial and multimodal datasets
7
Cancer indications
NSCLC, Ovarian, Bladder, Mesothelioma, Glioblastoma, Breast Cancer, DLBCL
6
Data modalities
Spatial transcriptomics, Single-cell RNA-seq, Bulk RNA-seq, Clinical data, WES, H&E
5
Academic partners
Gustave Roussy, University of Pittsburgh, Uniklinikum Erlangen, Charitè, CHUV
MOSAIC + Owkin
Follow our spatial biology journey
Owkin's MOSAIC dataset will allow us to decode the tumour microenvironment. We combine spatial omics with AI to decode complex biology and ensure every patient gets the right treatment.
MOSAIC Demo